Council E-E, Group EW. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transpl. 2021;36(1):87–94.

Article  Google Scholar 

Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105(1):37–55.

Article  CAS  PubMed  Google Scholar 

Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385(7):661–2.

Article  PubMed  Google Scholar 

Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med. 2022;386(6):509–20.

Article  PubMed  Google Scholar 

Saravolatz LD, Depcinski S, Sharma M. Molnupiravir and nirmatrelvir-ritonavir: oral coronavirus disease 2019 antiviral drugs. Clin Infect Dis. 2023;76(1):165–71.

Article  PubMed  Google Scholar 

Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327–36.

Article  CAS  PubMed  Google Scholar 

Elec AD, Oltean M, Goldis P, Cismaru C, Lupse M, Muntean A, Elec FI. COVID-19 after kidney transplantation: early outcomes and renal function following antiviral treatment. Int J Infect Dis. 2021;104:426–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elec F, Magnusson J, Elec A, Muntean A, Antal O, Moisoiu T, Cismaru C, Lupse M, Oltean M. COVID-19 and kidney transplantation: the impact of remdesivir on renal function and outcome - a retrospective cohort study. Int J Infect Dis. 2022;118:247–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poznański P, Augustyniak-Bartosik H, Magiera-Żak A, Skalec K, Jakuszko K, Mazanowska O, Janczak D, Krajewska M, Kamińska D. Molnupiravir when used alone seems to be safe and effective as outpatient COVID-19 therapy for hemodialyzed patients and kidney transplant recipients. Viruses. 2022;14(10):2224.

Article  PubMed  PubMed Central  Google Scholar 

Villamarín M, Márquez-Algaba E, Esperalba J, Perelló M, Los Arcos I, Campany D, Moreso F, Len O. Preliminary clinical experience of molnupiravir to prevent progression of COVID-19 in kidney transplant recipients. Transplantation. 2022;106(11):2200–4.

Article  PubMed  Google Scholar 

Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI, Ishihara T, Iwata M, Morise Z, Doi Y. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med. 2020;383(9):885–6.

Article  PubMed  Google Scholar 

Modelli de Andrade LG, de Sandes-Freitas TV, Requião-Moura LR, Viana LA, Cristelli MP, Garcia VD, Alcântara ALC, Esmeraldo RM, Abbud Filho M, Pacheco-Silva A, et al. Development and validation of a simple web-based tool for early prediction of COVID-19-associated death in kidney transplant recipients. Am J Transpl. 2022;22(2):610–25.

Article  CAS  Google Scholar 

Terada M, Ohtsu H, Saito S, Hayakawa K, Tsuzuki S, Asai Y, Matsunaga N, Kutsuna S, Sugiura W, Ohmagari N. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021;11(6):e047007.

Article  PubMed  Google Scholar 

Wong G, Rowlandson M, Sabanayagam D, Ginn AN, Kable K, Sciberras F, Au E, Draper J, Arnott A, Sintchenko V, et al. COVID-19 infection with the Omicron SARS-CoV-2 variant in a cohort of kidney and kidney pancreas transplant recipients: clinical features, risk factors, and outcomes. Transplantation. 2022;106(9):1860–6.

Article  CAS  PubMed  Google Scholar 

Radcliffe C, Palacios CF, Azar MM, Cohen E, Malinis M. Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge. Am J Transpl. 2022;22(10):2458–63.

Article  CAS  Google Scholar 

Raja MA, Mendoza MA, Villavicencio A, Anjan S, Reynolds JM, Kittipibul V, Fernandez A, Guerra G, Camargo JF, Simkins J, et al. COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature. Transpl Rev (Orlando). 2021;35(1):100588.

Article  Google Scholar 

Nevejan L, Ombelet S, Laenen L, Keyaerts E, Demuyser T, Seyler L, Soetens O, Van Nedervelde E, Naesens R, Geysels D, et al. Severity of COVID-19 among hospitalized patients: Omicron remains a severe threat for immunocompromised hosts. Viruses. 2022;14(12):2736.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, the Northwell C-RC, Barnaby DP, Becker LB, Chelico JD, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Finelli C, Parisi S. The clinical impact of COVID-19 epidemic in the hematologic setting. Adv Biol Regul. 2020;77:100742.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Li R, Liu S. Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: a novel intervention strategy beyond vaccines and specific antiviral medicines. J Med Virol. 2020;92(9):1495–500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Appelberg S, Gupta S, Svensson Akusjärvi S, Ambikan AT, Mikaeloff F, Saccon E, Végvári Á, Benfeitas R, Sperk M, Ståhlberg M, et al. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect. 2020;9(1):1748–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan N, mTOR. A possible therapeutic target against SARS-CoV-2 infection. Arch Stem Cell Ther. 2021;2(1):5–7.

PubMed  PubMed Central  Google Scholar 

Lopez-Vilella R, Sanchez-Lazaro I, Trenado VD, Edo SL, Dolz LM, Bonet LA. COVID-19 and heart transplantation. Initial experience in a tertiary hospital. Transplant Proc. 2021;53(9):2743-6.

Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, Nuño J, Gastaca M, Bustamante-Schneider J, Cachero A, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021;74(1):148–55.

Article  CAS  PubMed  Google Scholar 

Kijima Y, Shimizu T, Kato S, Kano K, Horiuchi T, Nozaki T, Omoto K, Inui M, Toma H, Iida S et al. Case report of COVID-19 infection after kidney transplant treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. Transplant Proc. 2022;54(6):1561-3.

Kirchner GI, Meier-Wiedenbach I, Manns MP. Clinical pharmacokinetics of everolimus. Clin Pharmacokinet. 2004;43(2):83–95.

Article  CAS  PubMed  Google Scholar 

Klawitter J, Nashan B, Christians U. Everolimus and sirolimus in transplantation-related but different. Expert Opin Drug Saf. 2015;14(7):1055–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Angelico R, Blasi F, Manzia TM, Toti L, Tisone G, Cacciola R. The management of Immunosuppression in kidney transplant recipients with COVID-19 disease: an update and systematic review of the literature. Med (Kaunas). 2021;57(5):435.

Google Scholar 

Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, Ryan P, Nielsen BU, Brown M, et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022;386(4):305–15.

Article  CAS  PubMed  Google Scholar 

Moromizato T, Sakaniwa R, Tokuda Y, Taniguchi K, Shibuya K. Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study. Crit Care. 2023;27(1):53.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, et al. Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic. Clin Exp Med. 2023;23(6):2715–23.

Article  CAS  PubMed  Google Scholar 

Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Baniecki M, Hendrick VM, Damle B, Simón-Campos A, et al. Oral nirmatrelvir for high-risk, nonhospitalized sdults with Covid-19. N Engl J Med. 2022;386(15):1397–408.

Article  CAS  PubMed  Google Scholar 

Fishbane S, Hirsch JS, Nair V. Special considerations for paxlovid treatment among transplant recipients with SARS-CoV-2 infection. Am J Kidney Dis. 2022;79(4):480–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devresse A, Sébastien B, De Greef J, Lemaitre F, Boland L, Haufroid V, Scohy A, Kabamba B, Yombi JC, Belkhir L, et al. Safety, efficacy, and relapse of nirmatrelvir-ritonavir in kidney transplant recipients infected with SARS-CoV-2. Kidney Int Rep. 2022;7(11):2356–63.

Article  PubMed  PubMed Central  Google Scholar 

Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, et al. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020;383(19):1813–26.

Article  CAS  PubMed